Steinbeck JA, Jaiswal MK, Calder EL, Kishinevsky S, Weishaupt A, Toyka KV, Goldstein PA, Studer L.
2016.
Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease.. Cell Stem Cell. 18(1):134-43.
Steinbeck JA, Jaiswal MK, Calder EL, Kishinevsky S, Weishaupt A, Toyka KV, Goldstein PA, Studer L.
2016.
Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease.. Cell Stem Cell. 18(1):134-43.
Kampaktsis PN, Ullal AV, Minutello RM, Feldman DN, Swaminathan RV, Voudris K, Baduashvili A, Pastella K, Pawar S, Kaple RK et al..
2016.
Impact of Paravalvular Aortic Insufficiency on Left Ventricular Remodeling and Mortality after Transcatheter Aortic Valve Replacement.. J Heart Valve Dis. 25(3):301-308.
Kampaktsis PN, Ullal AV, Minutello RM, Feldman DN, Swaminathan RV, Voudris K, Baduashvili A, Pastella K, Pawar S, Kaple RK et al..
2016.
Impact of Paravalvular Aortic Insufficiency on Left Ventricular Remodeling and Mortality after Transcatheter Aortic Valve Replacement.. J Heart Valve Dis. 25(3):301-308.
Kampaktsis PN, Ullal AV, Minutello RM, Feldman DN, Swaminathan RV, Voudris K, Baduashvili A, Pastella K, Pawar S, Kaple RK et al..
2016.
Impact of Paravalvular Aortic Insufficiency on Left Ventricular Remodeling and Mortality after Transcatheter Aortic Valve Replacement.. J Heart Valve Dis. 25(3):301-308.
Stiles BM, Poon A, Giambrone GP, Gaber-Baylis LK, Wu X, Lee PC, Port JL, Paul S, Bhat AU, Zabih R et al..
2016.
Incidence and Factors Associated With Hospital Readmission After Pulmonary Lobectomy.. Ann Thorac Surg. 101(2):434-43.
Sunaga H, Savarese JJ, McGilvra JD, Heerdt PM, Belmont MR, Van Ornum SG, Murrell MT, Malhotra JK, Savard PM, Jeannotte E et al..
2016.
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat.. Anesthesiology. 125(4):732-743.
Sunaga H, Savarese JJ, McGilvra JD, Heerdt PM, Belmont MR, Van Ornum SG, Murrell MT, Malhotra JK, Savard PM, Jeannotte E et al..
2016.
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat.. Anesthesiology. 125(4):732-743.
Sunaga H, Savarese JJ, McGilvra JD, Heerdt PM, Belmont MR, Van Ornum SG, Murrell MT, Malhotra JK, Savard PM, Jeannotte E et al..
2016.
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat.. Anesthesiology. 125(4):732-743.